GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 94 filers reported holding GALENA BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $42,000 | -61.1% | 89,296 | +30.4% | 0.00% | – |
| Q3 2015 | $108,000 | -7.7% | 68,465 | -0.4% | 0.00% | – |
| Q2 2015 | $117,000 | +515.8% | 68,747 | +402.2% | 0.00% | – |
| Q1 2015 | $19,000 | -20.8% | 13,688 | -15.2% | 0.00% | – |
| Q4 2014 | $24,000 | -50.0% | 16,150 | -30.1% | 0.00% | – |
| Q3 2014 | $48,000 | -21.3% | 23,106 | -4.7% | 0.00% | – |
| Q1 2014 | $61,000 | -50.8% | 24,241 | -2.7% | 0.00% | – |
| Q4 2013 | $124,000 | – | 24,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,446,469 | $13,616,000 | 2.03% |
| Harbour Capital Advisors, LLC | 78,450 | $196,000 | 0.19% |
| SABBY MANAGEMENT, LLC | 708,089 | $1,770,000 | 0.10% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 174,600 | $437,000 | 0.07% |
| Alyeska Investment Group, L.P. | 530,000 | $1,950,000 | 0.05% |
| HIGHLAND CAPITAL MANAGEMENT LP | 528,027 | $1,320,000 | 0.05% |
| KMS FINANCIAL SERVICES, INC | 118,042 | $295,000 | 0.05% |
| Quantitative Investment Management, LLC | 348,500 | $871,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 538,100 | $1,345,000 | 0.04% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $74,000 | 0.04% |